A 52-Week, Open-Label, Observational Study Evaluating Tolerability, Efficacy and Physicians Satisfaction of Rivastigmine Oral Solution in Alzheimer's Disease in Taiwan
Journal of Alzheimer's disease reports（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined